ACM
AMGN icon

AlphaCrest Capital Management’s Amgen AMGN Stock Holding History

AlphaCrest Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,092
Closed -$472K – 66
2022
Q3 		$472K Sell
2,092
-42,694
-95% -$10.3M 0.03% 998
2022
Q2 		$10.9M Buy
44,786
+38,631
+628% +$9.47M 0.53% 10
2022
Q1 		$1.49M Sell
6,155
-18,970
-76% -$4.36M 0.08% 365
2021
Q4 		$5.65M Buy
25,125
+46
+0.2% +$9.71K 0.21% 75
2021
Q3 		$5.33M Buy
25,079
+22,413
+841% +$5.16M 0.28% 47
2021
Q2 		$650K Buy
+2,666
New +$656K 0.03% 854
2021
Q1 		– Sell
-8,300
Closed -$1.91M – 1173
2020
Q4 		$1.91M Buy
8,300
+6,879
+484% +$1.59M 0.16% 146
2020
Q3 		$361K Buy
1,421
+175
+14% +$43.4K 0.04% 772
2020
Q2 		$294K Sell
1,246
-9,566
-88% -$2.18M 0.05% 640
2020
Q1 		$2.19M Buy
10,812
+5,565
+106% +$1.22M 0.27% 55
2019
Q4 		$1.26M Sell
5,247
-15,182
-74% -$3.35M 0.1% 248
2019
Q3 		$3.95M Buy
20,429
+15,365
+303% +$2.95M 0.24% 63
2019
Q2 		$933K Sell
5,064
-10,826
-68% -$1.94M 0.08% 431
2019
Q1 		$3.02M Buy
+15,890
New +$3.03M 0.46% 23

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AlphaCrest Capital Management's AMGN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 2,092 shares — an estimated $472K sold.

AlphaCrest Capital Management first reported a position in AMGN in Q1 2019 and held it in 14 quarters. The position peaked at $10.9M in Q2 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 2,092 Amgen shares in Q4 2022, an estimated $472K.
  • AlphaCrest Capital Management first reported a position in Amgen in Q1 2019 and held it in 14 quarters.
  • AlphaCrest Capital Management's Amgen position peaked at $10.9M in Q2 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.